Endothelial FOS expression and pre-eclampsia.

Area of Science:

• Obstetrics and Gynecology
• Molecular Biology
• Genetics

Background:

• Pre-eclampsia is a serious pregnancy complication characterized by high blood pressure.
• Endothelial cell dysfunction is implicated in the pathophysiology of pre-eclampsia.
• Understanding molecular changes in endothelial cells exposed to pregnancy plasma is crucial.

Purpose of the Study:

• To investigate gene expression profiles in human endothelial cells exposed to plasma from women who developed pre-eclampsia versus normotensive pregnancies.
• To identify specific genes and pathways affected by plasma factors during gestation.

Main Methods:

• A longitudinal nested case-control study involving 12 pregnant women (6 pre-eclampsia, 6 controls).
• Human umbilical vein endothelial cells (HUVECs) were incubated with plasma collected at 16 and 28 weeks gestation.
• Gene expression profiling was performed using microarrays, with validation via quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR).

Main Results:

• Significant differences in gene expression were observed between cells incubated with plasma from cases and controls.
• Plasma from pre-eclamptic women led to increased expression of 11 genes, while control plasma affected 25 genes.
• A notable finding was the increased expression of the c-Fos gene (FOS) with control plasma, but not with plasma from women who developed pre-eclampsia.

Conclusions:

• Plasma from women who later develop pre-eclampsia contains factors that dysregulate c-Fos expression in endothelial cells.
• Reduced c-Fos expression in endothelial cells might impair vasculogenesis.
• This dysregulation could be a contributing factor to the development of pre-eclampsia.